Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • Diagnostics Market Research
  • Healthcare Market Research
  • Medical Devices Market Research
  • Pharmaceuticals Market Research

DiagnosticsX

Kalorama Information is the authoritative market research source for the diagnostics industry. Find essential insights, market shares, sales segmentation and projections for in vitro diagnostics (IVD) and medical imaging markets. Kalorama’s reports, including The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 13th edition, analyze the global in vitro diagnostics market, now worth approximately $83.3 billion. Our diagnostics market research covers trends in health care service delivery, including the rapidly advancing diagnostic laboratory technology industry. Discover emerging diagnostics market niches in our updated reports that present the trends, technologies, customer needs, and major suppliers currently shaping the diagnostics industry.
Molecular Assays
Point-of-Care
Immunoassays
Infectious Disease
Clinical Chemistry
Oncology/Hematology
Lab Testing Services
Medical Imaging

  • The Worldwide Market for Laboratory-Developed Tests (LDTs)
    $5,500 – $11,000
    Laboratory developed tests (LDTs) are not a new or recent phenomenon but due to the incredible need for testing of SARS-CoV-2, there has been a flood of new tests and the regulatory guidance has changed dramatically.  Historically, these tests were called “home-brew tests” or “in-house tests.”  Also, historically, these tests were low-volume, simple and well […]
    September 24, 2020
  • IVD Market Infographic
    The Worldwide Market for In Vitro Diagnostic Tests, 13th Edition
    $8,250 – $16,500
    The most essential report on the IVD industry, this 1,500-plus page report has provided reliable estimates and real-world forecasts for the in vitro diagnostics industry for two decades.
    July 31, 2020
  • Benchmarking for 2021: Understanding the Clinical Diagnostics Customer Experience
    $3,750 – $7,000
    Customer experience in the clinical diagnostics industry is increasingly a target for improving overall customer satisfaction and a potential opportunity for differentiation beyond product performance, service plans, and price. This Kalorama Information report is an essential tool to learn how the in vitro diagnostics industry is seen from the point of view of their customers. […]
    July 27, 2020
  • Digital Pathology: Markets, Trends, Companies and COVID-19 Impact
    $3,500 – $7,000
    Digital pathology is the technique of analyzing high-resolution digitally scanned histology images, which may then be analyzed using computational tools and algorithms.  Digital pathology is enabled in part by virtual microscopy, a method of capturing microscopic images and transmitting them over computer networks.  This allows independent viewing of images by large numbers of people in […]
    July 24, 2020
  • COVID-19 Clinical Lab Tracker
    $4,000
    Trended bi-weekly data from March 26 to June 15th, and monthly from July to December. New purchasers will receive all historical data from March to December. Click here to download a brochure and sample data. This clinical diagnostics COVID-19 lab impacts tracker is produced through a continuous survey of clinical lab professionals at hundreds of […]
    2020Q2
  • Molecular Diagnostics Markets in the COVID-19 Era (Markets for COVID-19 IVD Tests, Respiratory Tests, Blood Screening, Cancer Markers and Other IVD Tests)
    $5,500 – $11,000
    Molecular Diagnostics could be said to be the most important part of in vitro diagnostics.  This is especially true in the wake of COVID-19.  Kalorama Information has, for many years, estimated the size of and forecasted the growth of the worldwide market for these important in vitro diagnostic tests in all major segments, and does […]
    July 9, 2020
  • Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities
    $6,000 – $12,000
    Kalorama Information’s report provides a comprehensive market analysis and business planning tool for the market for tests that are aligned with a pharmaceutical treatment.  Especially in oncology, companion diagnostics are rising to the forefront of pharmaceutical development and treatment. Companion diagnostics increase the probability of clinical success by identifying patients with the presence of biomarkers […]
    June 17, 2020
  • Emerging Infectious Disease Diagnostics: Markets and Trends
    $3,000 – $6,000
    In light of the COVID-19 (coronavirus) pandemic, it is extremely timely to present a report on the status quo in emerging infectious diseases. While the current pandemic is troublesome and has disrupted normal life, it will follow its course and then fade away.  Where could the next pandemic or epidemic come from?   There are a number […]
    May 27, 2020
  • Hematology and Coagulation Markets (Lab-based and Decentralized Markets)
    $5,000 – $10,000
    Kalorama Information’s Hematology and Coagulation Markets (Lab-based and Decentralized Markets) examines the current state of two growing testing markets. Hematology is the study of peripheral blood and bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia and autoimmune diseases. The menu of hematology tests includes: CBC + 5-part differential […]
    May 19, 2020
  • Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets
    $4,000 – $8,000
    CLICK HERE TO VIEW NEW VERSION OF THIS REPORT The current COVID-19 crisis affecting the United States and the world has caused hundreds of thousands of deaths and countless economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the […]
    May 14, 2020